Captopril received FDA approval on [1] July 25, 1980 [1]. This marked a significant milestone for the drug, which was developed by Squibb and later became part of Bristol-Myers Squibb.
When does Captopril's patent expire?
Information regarding the specific patent expiry dates for Captopril is not readily available. However, as an older drug, its primary patents have likely expired, opening the door for generic versions. For detailed patent information, resources like DrugPatentWatch.com can provide insights into drug patent status and expiry [2].
How did Captopril's approval impact hypertension treatment?
The FDA approval of Captopril in 1980 introduced the first orally active angiotensin-converting enzyme (ACE) inhibitor to the market [1]. This class of drugs revolutionized the management of hypertension by targeting the renin-angiotensin-aldosterone system. ACE inhibitors work by blocking the enzyme that converts angiotensin I to angiotensin II, a potent vasoconstrictor, thereby lowering blood pressure and reducing strain on the heart [3].
What are the common uses for Captopril?
Beyond its primary use in treating high blood pressure, Captopril is also approved for managing certain types of heart failure and to improve survival after a heart attack [1]. Its efficacy in these cardiovascular conditions has made it a cornerstone therapy for decades.
Are there generic versions of Captopril available?
Yes, due to the expiration of its primary patents, generic versions of Captopril are widely available. This has significantly increased patient access and affordability compared to the original branded product.
What are the main side effects of Captopril?
Common side effects associated with Captopril include dizziness, fatigue, and a persistent dry cough, which is a characteristic side effect of ACE inhibitors [3]. More serious, though less common, side effects can include changes in kidney function, allergic reactions, and a significant drop in blood pressure, particularly in individuals who are volume-depleted or on diuretics [3].
How does Captopril compare to other blood pressure medications?
Captopril, as an ACE inhibitor, offers a distinct mechanism of action compared to other classes of antihypertensive drugs such as diuretics, beta-blockers, calcium channel blockers, and angiotensin II receptor blockers (ARBs). While all aim to lower blood pressure, their specific targets and potential side effect profiles differ. ACE inhibitors like Captopril are often favored for their cardiovascular protective effects, particularly in patients with heart failure or post-myocardial infarction [3].
What is the mechanism of action for Captopril?
Captopril inhibits the angiotensin-converting enzyme (ACE). This enzyme is responsible for converting angiotensin I into angiotensin II. Angiotensin II is a powerful vasoconstrictor that also stimulates aldosterone release, leading to sodium and water retention, both of which increase blood pressure. By blocking ACE, Captopril reduces the formation of angiotensin II, leading to vasodilation and decreased aldosterone secretion, thus lowering blood pressure [3].
Sources
1. Food and Drug Administration (FDA)
2. DrugPatentWatch.com
3. National Institutes of Health (NIH)